A patient on warfarin starts taking fluconazole for a vaginal yeast infection. What is the expected pharmacokinetic interaction?
-
A
Fluconazole inhibits CYP2C9, increasing warfarin levels and INR — increased bleeding risk
-
B
Fluconazole induces CYP2C9, decreasing warfarin levels
-
C
No interaction — fluconazole only affects CYP3A4
-
D
Fluconazole enhances warfarin absorption from the GI tract